Rezolute, Inc. current report, 08 March 2024

Rezolute, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Rezolute, Inc. (Nasdaq: RZLT) on March 14, 2024, covering events that occurred on March 8, 2024. The filing discloses a material definitive agreement regarding a securities exchange and a change in the company's independent registered public accounting firm.

Key Financial Metrics

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. The only specific financial figure disclosed relates to the securities exchange transaction:

  • Transaction Consideration: The Company paid an aggregate purchase price of $3,000 to Exchanging Stockholders for the retirement of 3,000,000 shares of common stock.
  • Capital Structure Impact: The number of issued and outstanding shares of common stock was reduced by 3,000,000 shares.

Material Changes

The filing details two significant corporate actions:

  1. Securities Exchange Agreement: The Company entered into an agreement to exchange 3,000,000 shares of common stock owned by certain stockholders for pre-funded warrants (Exchange Warrants) to purchase an equivalent number of shares. The exercise price of these warrants is $0.001 per share. The retired shares were cancelled under Nevada law.
  2. Change in Auditors: The Company dismissed Plante & Moran, PLLC as its independent registered public accounting firm and appointed Grant Thornton LLP as its new auditor. The dismissal was approved unanimously by the Audit Committee.

Guidance, Risks, and Contingencies

Management Commentary and Restrictions:

  • The Exchange Warrants are exercisable at any time, subject to beneficial ownership limitations (cannot be exercised if the holder would own more than 9.99% of common stock, with exceptions).
  • Warrant holders do not have voting rights except as required by Nevada law.
  • The Company agreed to file a registration statement within six months of the transaction closing to cover the resale of shares issuable upon exercise of the warrants.
Risks and Contingencies:
  • Internal Controls: The filing notes a previously disclosed material weakness in internal controls over financial reporting (from the 2022 10-K) as the only "reportable event" during the tenure of the former auditor.
  • Legal Disclaimer: Representations and warranties in the Exchange Agreement were made solely for the benefit of the parties and should not be relied upon by investors as representing the current state of affairs.

Investor Verification Checklist

  • Verify the impact of the 3,000,000 share reduction on the total outstanding share count and potential dilution from the new pre-funded warrants.
  • Review the full text of the Securities Exchange Agreement (Exhibit 10.1) and Form of Exchange Warrant (Exhibit 4.1) for specific terms regarding the 9.99% beneficial ownership limitation.
  • Confirm the status of the material weakness in internal controls over financial reporting and any remediation plans implemented since the 2022 disclosure.
  • Monitor the filing of the registration statement for the resale of warrant shares, which is due within six months of March 8, 2024.